UNSPSC 41202066: Treponema pallidumtreponemal test reagents

In this classification, Treponema pallidum treponemal test reagents are devices used in test to identify specific Treponema pallidum treponemal test reagents antibodies in serum. US FDA regulates Treponema pallidum treponemal test reagents under 21 CFR 866.3830 and under FDA product code GMS.

UNSPSC 41202066 Treponema pallidum treponemal test reagents (Commodity) covers HIV and Syphilis diagnostic testing supplies that state and local health departments, criminal justice agencies, and public health programs procure for screening, confirmation, and disease surveillance operations. Recent solicitations show state and local buyers acquiring rapid HIV test kits, Abbott-manufactured HIV/Syphilis reagents and controls, fourth-generation combination assays capable of simultaneous Hepatitis B, Hepatitis C, HIV, and Syphilis detection, and related consumables for fully automated laboratory analyzers. Issuing bodies span state health departments (Illinois Department of Public Health), county criminal justice and community supervision agencies (Collin County Community Supervision and Corrections Department in Texas), and municipal public health programs (City of Austin). The work encompasses both high-volume offender drug and disease testing programs operated by county corrections departments and routine public health screening and surveillance conducted by state laboratories and city health departments.

Recent activity concentrates in Texas and Illinois. The Illinois Department of Public Health Division of Laboratories has issued multiple procurements since February 2026, including a five-year IFB for Hepatitis/HIV/Syphilis fourth-generation assay screening and instrumentation (IFB posted February 13, 2026, due March 16, 2026) supporting Jackson County operations with approximately 13,200 HIV tests annually, and emergency sole-source awards to Abbott Laboratories for HIV/Syphilis reagents totaling $38,079.50. In Texas, Collin County Community Supervision and Corrections Department issued RFP 2026-327 for offender specimen collection and drug testing services (posted July 9, 2026, due July 23, 2026) covering approximately 25,031 annual tests at an estimated contract value of $600,000 over two years with three optional renewals; and the City of Austin released IFB 9100AAM1023 for Abbott Determine HIV test kits (posted June 15, 2026, due July 17, 2026) for the Austin Public Health Program. The Texas Department of Criminal Justice also solicited forensic laboratory testing services including serology work (RFP 696-IG-26-P034, posted April 13, 2026, due May 13, 2026). Award structures vary from sole-source emergency buys to competitive IFBs and RFPs with multiple-award provisions and optional renewal periods extending to five years.